Acadian Asset Management LLC Harvard Bioscience Inc Transaction History

Acadian Asset Management LLC

  • $32.2 Billion
  • Q3 2024

A detailed history of Acadian Asset Management LLC transactions in Harvard Bioscience Inc stock. As of the latest transaction made, Acadian Asset Management LLC holds 873,614 shares of HBIO stock, worth $1.9 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
873,614
Previous 963,106 9.29%
Holding current value
$1.9 Million
Previous $2.74 Million 14.47%
% of portfolio
0.01%
Previous 0.01%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024
SELL
$2.64 - $3.54 $236,258 - $316,801
-89,492 Reduced 9.29%
873,614 $2.35 Million
Q2 2024

Aug 06, 2024
SELL
$2.77 - $4.63 $113,545 - $189,788
-40,991 Reduced 4.08%
963,106 $2.74 Million
Q1 2024

May 10, 2024
SELL
$4.02 - $5.39 $23,127 - $31,008
-5,753 Reduced 0.57%
1,004,097 $4.26 Million
Q4 2023

Feb 13, 2024
SELL
$4.0 - $5.49 $216,028 - $296,498
-54,007 Reduced 5.08%
1,009,850 $5.4 Million
Q3 2023

Nov 13, 2023
SELL
$4.0 - $5.82 $165,584 - $240,924
-41,396 Reduced 3.75%
1,063,857 $4.57 Million
Q4 2022

Feb 14, 2023
BUY
$2.12 - $2.86 $56,972 - $76,859
26,874 Added 2.49%
1,105,253 $3.06 Million
Q3 2022

Nov 14, 2022
BUY
$2.33 - $3.92 $68,851 - $115,836
29,550 Added 2.82%
1,078,379 $2.76 Million
Q2 2022

Aug 09, 2022
SELL
$3.28 - $6.42 $60,630 - $118,673
-18,485 Reduced 1.73%
1,048,829 $3.78 Million
Q1 2022

May 12, 2022
SELL
$5.16 - $7.14 $364,265 - $504,041
-70,594 Reduced 6.2%
1,067,314 $6.63 Million
Q4 2021

Feb 10, 2022
SELL
$6.37 - $8.18 $34,538 - $44,351
-5,422 Reduced 0.47%
1,137,908 $8.02 Million
Q3 2021

Nov 12, 2021
BUY
$6.98 - $8.47 $472,357 - $573,190
67,673 Added 6.29%
1,143,330 $7.98 Million
Q2 2021

Aug 11, 2021
BUY
$5.44 - $8.4 $303,508 - $468,652
55,792 Added 5.47%
1,075,657 $8.96 Million
Q1 2021

May 11, 2021
SELL
$3.91 - $6.99 $300,198 - $536,671
-76,777 Reduced 7.0%
1,019,865 $5.57 Million
Q4 2020

Feb 11, 2021
BUY
$3.0 - $4.5 $20,412 - $30,618
6,804 Added 0.62%
1,096,642 $4.7 Million
Q3 2020

Nov 09, 2020
SELL
$2.75 - $4.2 $31,732 - $48,463
-11,539 Reduced 1.05%
1,089,838 $3.28 Million
Q2 2020

Aug 12, 2020
BUY
$2.12 - $3.14 $62,359 - $92,363
29,415 Added 2.74%
1,101,377 $3.41 Million
Q1 2020

May 11, 2020
BUY
$1.42 - $3.29 $16,320 - $37,811
11,493 Added 1.08%
1,071,962 $2.37 Million
Q4 2019

Feb 06, 2020
SELL
$2.45 - $3.25 $52,192 - $69,234
-21,303 Reduced 1.97%
1,060,469 $3.23 Million
Q3 2019

Nov 07, 2019
BUY
$1.59 - $3.47 $47,292 - $103,211
29,744 Added 2.83%
1,081,772 $3.33 Million
Q2 2019

Aug 08, 2019
BUY
$1.93 - $4.59 $542,895 - $1.29 Million
281,293 Added 36.5%
1,052,028 $2.1 Million
Q1 2019

May 09, 2019
SELL
$2.77 - $4.38 $105,852 - $167,377
-38,214 Reduced 4.72%
770,735 $3.32 Million
Q4 2018

Feb 07, 2019
SELL
$3.03 - $5.0 $138,319 - $228,250
-45,650 Reduced 5.34%
808,949 $2.57 Million
Q3 2018

Oct 30, 2018
BUY
$5.0 - $6.65 $8,515 - $11,324
1,703 Added 0.2%
854,599 $4.48 Million
Q2 2018

Jul 24, 2018
BUY
$4.2 - $5.95 $20,504 - $29,047
4,882 Added 0.58%
852,896 $4.56 Million
Q1 2018

Apr 12, 2018
BUY
$3.3 - $5.15 $466,851 - $728,570
141,470 Added 20.02%
848,014 $4.24 Million
Q4 2017

Jan 18, 2018
SELL
$3.08 - $3.8 $9,889 - $12,201
-3,211 Reduced 0.45%
706,544 $2.33 Million
Q3 2017

Oct 13, 2017
BUY
$2.7 - $3.75 $1.92 Million - $2.66 Million
709,755
709,755 $2.67 Million

Others Institutions Holding HBIO

# of Institutions
96
Shares Held
31.5M
Call Options Held
700
Put Options Held
2.1K
View Full List

About HARVARD BIOSCIENCE INC

HBIO Quotes by TradingView
  • Ticker HBIO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 41,636,500
  • Market Cap $90.4M
  • Description
  • Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products, and services that enables fundamental research, discovery, and pre-clinical testing for drug development in the United States and internationally. The company offers cellular and molecular technology instruments, such as syringe and peristaltic pump products, as w...
More about HBIO
Track This Portfolio

Track Acadian Asset Management LLC Portfolio

Follow Acadian Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Acadian Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Acadian Asset Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email